Treosulphan-based radiation-free myeloablative conditioning for allogeneic transplant in infant acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 159, Issue 1, 2012, Pages 104-106

  Corker, Emma ^a   Astwood, Emma ^a   Williams, Janet ^a   Vora, Ajay ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEFIBROTIDE; METHOTREXATE; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY; TREOSULFAN; URSODEOXYCHOLIC ACID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE INFECTION; HIGH RISK PATIENT; HUMAN; INFANT; KLEBSIELLA INFECTION; LETTER; LEUKEMIA RELAPSE; LIVER VENOOCCLUSIVE DISEASE; MALE; MICROANGIOPATHY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MYELOABLATIVE CONDITIONING; NEWBORN; PRIORITY JOURNAL; RADIATION FREE MYELOABLATIVE CONDITIONING; SKIN DISEASE; TREATMENT RESPONSE; VIRAL BRONCHIOLITIS;

ANTINEOPLASTIC AGENTS, ALKYLATING; BUSULFAN; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84866335537     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09228.x     Document Type: Letter

References (10)

1. Cutting, R., Mirelman, A. & Vora, A. (2008) Treosulphan as an alternative to busulphan for myeloablative conditioning in paediatric allogeneic transplantation. British Journal of Haematology, 143, 748-751.
2. Davies, S.M., Ramsay, N.K.C., Klein, J.P., Weisdorf, D.J., Bolwell, B., Cahn, J.Y., Camitta, B.M., Gale, R.P., Giralt, S., Heilmann, C., Henslee-Downey, P.J., Herzig, R.H., Hutchinson, R., Keating, A., Lazarus, H.M., Milone, G.A., Neudorf, S., Perez, W.S., Powles, R.L., Prentice, H.G., Schiller, G., Socié, G., Vowels, M., Wiley, J., Yeager, A. & Horowitz, M.M. (2000) Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 18, 340-347.
3. Dreyer, Z.E., Dinndorf, P.A., Camitta, B., Sather, H., La, M.K., Devidas, M., Hilden, J.M., Heerema, N.A., Sanders, J.E., McGlennen, R., Willman, C.L., Carroll, A.J., Behm, F., Smith, F.O., Woods, W.G., Godder, K. & Reaman, G.H. (2011) Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and mll gene rearrangements: a report from the children's oncology group. Journal of Clinical Oncology, 29, 214-222.
4. Jacobsohn, D.A., Hewlett, B., Morgan, E., Tse, W., Duerst, R.E. & Kletzel, M. (2005) Favorable outcome for infant acute lymphoblastic leukemia after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 11, 999-1005.
5. Mann, G., Attarbaschi, A., Schrappe, M., De Lorenzo, P., Peters, C., Hann, I., De Rossi, G., Felice, M., Lausen, B., LeBlanc, T., Szczepanski, T., Ferster, A., Janka-Schaub, G., Rubnitz, J., Silverman, L.B., Stary, J., Campbell, M., Li, C.K., Suppiah, R., Biondi, A., Vora, A., Valsecchi, M.G. & Pieters, R. (2010) Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the interfant-99 study. Blood, 116, 2644-2650.
6. Munkelt, D., Koehl, U., Kloess, S., Zimmermann, S.Y., Kalaäoui, R.E., Wehner, S., Schwabe, D., Lehrnbecher, T., Schubert, R., Kreuter, J., Klingebiel, T. & Esser, R. (2008) Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients. Cancer Chemotherapy and Pharmacology, 62, 821-830.
7. Sanders, J.E., Im, H.J., Hoffmeister, P.A., Gooley, T.A., Woolfrey, A.E., Carpenter, P.A., Andrews, R.G., Bryant, E.M. & Appelbaum, F.R. (2005) Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia. Blood, 105, 3749-3756.
8. Scheulen, M.E., Hilger, R.A., Oberhoff, C., Casper, J., Freund, M., Josten, K.M., Bornhauser, M., Ehninger, G., Berdel, W.E., Baumgart, J., Harstrick, A., Bojko, P., Wolf, H.H., Schindler, A.E. & Seeber, S. (2000) Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies. Clinical Cancer Research, 6, 4209-4216.
9. Sjöö, F., Hassan, Z., Abedi-Valugerdi, M., Griskevicius, L., Nilsson, C., Remberger, M., Aschan, J., Concha, H., Gaughan, U. & Hassan, M. (2006) Myeloablative and immunosuppressive properties of treosulfan in mice. Experimental Hematology, 34, 115-121.
10. Wachowiak, J., Sykora, K.W., Cornish, J., Chybicka, A., Kowalczyk, J.R., Gorczyska, E., Choma, M., Grund, G. & Peters, C. (2011) Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party. Bone Marrow Transplantation, 46, 1510-1518.